Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Investing Activities: 2019-2024

Historic Cash from Investing Activities for Molecular Partners Ag (MOLN) over the last 6 years, with Dec 2024 value amounting to $46.0 million.

  • Molecular Partners Ag's Cash from Investing Activities fell 75.86% to -$62.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.1 million, marking a year-over-year decrease of 9.67%. This contributed to the annual value of $46.0 million for FY2024, which is 7.40% down from last year.
  • According to the latest figures from FY2024, Molecular Partners Ag's Cash from Investing Activities is $46.0 million, which was down 7.40% from $49.7 million recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's Cash from Investing Activities peaked at $49.7 million during FY2023, and registered a low of -$105.0 million during FY2022.
  • Its 3-year average for Cash from Investing Activities is -$3.1 million, with a median of $46.0 million in 2024.
  • Per our database at Business Quant, Molecular Partners Ag's Cash from Investing Activities plummeted by 335.25% in 2022 and then soared by 147.35% in 2023.
  • Over the past 5 years, Molecular Partners Ag's Cash from Investing Activities (Yearly) stood at -$24.1 million in 2020, then dropped by 0.26% to -$24.1 million in 2021, then tumbled by 335.25% to -$105.0 million in 2022, then skyrocketed by 147.35% to $49.7 million in 2023, then decreased by 7.40% to $46.0 million in 2024.